TI
EBS icon

Tidal Investments’s Emergent Biosolutions EBS Stock Holding History

Tidal Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,460
Closed -$78.2K – 1871
2024
Q2 		$78.2K Sell
11,460
-1,892
-14% -$8.14K ﹤0.01% 1753
2024
Q1 		$33.8K Buy
+13,352
New +$30.1K ﹤0.01% 1635
2023
Q3 		– Sell
-15,795
Closed -$116K – 1317
2023
Q2 		$116K Sell
15,795
-788
-5% -$7.31K ﹤0.01% 1247
2023
Q1 		$172K Buy
16,583
+869
+6% +$10.5K 0.01% 1213
2022
Q4 		$186K Buy
+15,714
New +$243K 0.01% 1012

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Tidal Investments's EBS Position: Q3 2024 in Review

Tidal Investments sold out of Emergent Biosolutions (EBS) in Q3 2024, closing a stake of 11,460 shares — an estimated $78.2K sold.

Tidal Investments first reported a position in EBS in Q4 2022 and held it in 5 quarters. The position peaked at $186K in Q4 2022. 140 funds tracked by Wall St. Rank hold EBS as of Q3 2024.

  • Tidal Investments reported no remaining Emergent Biosolutions position as of Q3 2024 after selling out during the quarter.
  • Tidal Investments sold 11,460 Emergent Biosolutions shares in Q3 2024, an estimated $78.2K.
  • Tidal Investments first reported a position in Emergent Biosolutions in Q4 2022 and held it in 5 quarters.
  • Tidal Investments's Emergent Biosolutions position peaked at $186K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2024.

Based on Tidal Investments's 13F filing for Q3 2024, filed 14 Nov 2024.